Back

Which evidence for 'guided' de-escalation post ACS?

3 November 2023 (09:07 - 09:26)
Organised by: Logo
Seminar Presentation Part of: Combined antithrombotic therapy in patients with obstructive coronary artery disease Cardiovascular Pharmacotherapy Open Access EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy WG on Cardiovascular Pharmacotherapy

About the speaker

Photo
Professor Bianca Rocca

LUM University, Casamassima (Italy)

3 More presentations in this session

Presentation thumbnail
Plaque healing: from clinical events to therapeutic implications
Professor F. Crea (Rome, IT)
Presentation thumbnail
Acute Coronary Syndromes and revascularization in patients with Atrial Fibrillation: how many antithrombotic drugs and for how long?
Professor C. Di Mario (Florence, IT)
Presentation thumbnail
Discussion

Access the full session

Session thumbnail
Combined antithrombotic therapy in patients with obstructive coronary artery disease

The Event

Event poster

EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy

3 November 2023 09:07 CET
You may be interested in
thumbnail
Congress Presentation
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome and multivessel coronary artery disease: a post-hoc analysis of the TROPICAL-ACS trial
31 August 2019
thumbnail
ESC TV Today
Episode 4: Heart disease in dialysis patients - Substance abuse and heart disease
7 November 2024
thumbnail
Congress Presentation
De-escalating treatments and transitioning care in a cardiac intensive care units network
9 March 2024
thumbnail
Webinar
Transition of care to prevent recurrence after acute coronary syndrome: 100 days after discharge
7 December 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources